AU2003238883A1 - A novel amorphous form of (2-(4-((4-chlorophenyl)-phenyl methyl)-1- piperazinyl) ethoxy) acetic acid dihydrochloride (cetirizine dihydrochloride) - Google Patents

A novel amorphous form of (2-(4-((4-chlorophenyl)-phenyl methyl)-1- piperazinyl) ethoxy) acetic acid dihydrochloride (cetirizine dihydrochloride)

Info

Publication number
AU2003238883A1
AU2003238883A1 AU2003238883A AU2003238883A AU2003238883A1 AU 2003238883 A1 AU2003238883 A1 AU 2003238883A1 AU 2003238883 A AU2003238883 A AU 2003238883A AU 2003238883 A AU2003238883 A AU 2003238883A AU 2003238883 A1 AU2003238883 A1 AU 2003238883A1
Authority
AU
Australia
Prior art keywords
dihydrochloride
piperazinyl
chlorophenyl
ethoxy
acetic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003238883A
Other versions
AU2003238883A8 (en
Inventor
Srinivasan Thirumalai Rajan
Manne Satyanarayana Reddy
Ranga Ravi Shankar
Sunkara Vishnu Vardhan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Original Assignee
Dr Reddys Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Laboratories Ltd filed Critical Dr Reddys Laboratories Ltd
Publication of AU2003238883A8 publication Critical patent/AU2003238883A8/en
Publication of AU2003238883A1 publication Critical patent/AU2003238883A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003238883A 2002-06-05 2003-06-04 A novel amorphous form of (2-(4-((4-chlorophenyl)-phenyl methyl)-1- piperazinyl) ethoxy) acetic acid dihydrochloride (cetirizine dihydrochloride) Abandoned AU2003238883A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN425CH2002 2002-06-05
IN425/MAS/2002 2002-06-05
PCT/US2003/017600 WO2003104212A1 (en) 2002-06-05 2003-06-04 A novel amorphous form of [2-[4-[(4-chlorophenyl)-phenyl methyl]-1- piperazinyl] ethoxy] acetic acid dihydrochloride (cetirizine dihydrochloride)

Publications (2)

Publication Number Publication Date
AU2003238883A8 AU2003238883A8 (en) 2003-12-22
AU2003238883A1 true AU2003238883A1 (en) 2003-12-22

Family

ID=29727193

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2003237394A Abandoned AU2003237394A1 (en) 2002-06-05 2003-06-04 Crystalline (2-(4-((4-chlorophenyl)-phenyl methyl)-1-piperazinyl) ethoxy) acetic acid dihydrochloride
AU2003238883A Abandoned AU2003238883A1 (en) 2002-06-05 2003-06-04 A novel amorphous form of (2-(4-((4-chlorophenyl)-phenyl methyl)-1- piperazinyl) ethoxy) acetic acid dihydrochloride (cetirizine dihydrochloride)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2003237394A Abandoned AU2003237394A1 (en) 2002-06-05 2003-06-04 Crystalline (2-(4-((4-chlorophenyl)-phenyl methyl)-1-piperazinyl) ethoxy) acetic acid dihydrochloride

Country Status (2)

Country Link
AU (2) AU2003237394A1 (en)
WO (2) WO2003104211A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040186112A1 (en) * 2002-12-04 2004-09-23 Dr. Reddy's Laboratories Limited Polymorphic forms of dihydrochloride salts of cetirizine and processes for preparation thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO155805C (en) * 1981-02-06 1987-06-10 Ucb Sa ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVITY 2- (4- (DIPHENYLMETHYL) -1-PIPERAZINYL) -ACDIC ACIDS AND THEIR AMIDS AND NON-TOXIC SALTS.
GB8827390D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
BE1010095A3 (en) * 1996-04-10 1997-12-02 Ucb Sa METHOD OF PREPARATION OF ACID 2- [2- [4 - [(4-Chlorophenyl) phenylmethyl] -1-PIPERAZINYL] ETHOXY] acetic acid AND ITS SALTS.
DK176706B1 (en) * 1999-03-04 2009-03-30 Sandoz As Process for the preparation of 2- {2- [4- (diphenylmethyl) -1-piperazinyl] ethoxy} -acetic acid compounds or salts thereof
US6239277B1 (en) * 1999-10-20 2001-05-29 Salsbury Chemicals, Inc. Process for preparing piperazine-substituted aliphatic carboxylates
JP4763954B2 (en) * 1999-11-30 2011-08-31 エギシュ ヂョヂセルヂャール ニルヴァーノサン ミケデ レースヴェーニタールササーグ Process for the production of {2- [4- (α-phenyl-p-chlorobenzyl) piperazin-1-yl] ethoxy} acetic acid and novel intermediates therefor
EP1120109A3 (en) * 2000-01-24 2002-07-10 Pfizer Products Inc. Rapidly disintegrating and fast dissolving solid dosage form

Also Published As

Publication number Publication date
WO2003104211A3 (en) 2004-12-23
AU2003238883A8 (en) 2003-12-22
WO2003104211A2 (en) 2003-12-18
AU2003237394A8 (en) 2003-12-22
WO2003104212A1 (en) 2003-12-18
AU2003237394A1 (en) 2003-12-22

Similar Documents

Publication Publication Date Title
ZA200205265B (en) A novel crystalline form of N-[4-[2-[2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]L-glutamic acid and process therefor.
PL2281815T3 (en) 4-(Acetylamino)-3-[(4-chlorophenyl)thio]-2-methyl-1H-indole-1-acetic acid ethyl ester intermediate compound
LU92025I2 (en) 3-¬ (2- {¬4- (Hexyloxy-carbonylamino-imino-methyl) -phenylamino-methyl} -1-methyl-1H-benzimidazol-5-carbonyl) -pyridin-2-yl ethyl ester methanesulfonate -amino-propionic acid
PT1237855E (en) (S) -2-ETOXY-3 - [4- (2- {4-METHOSULPHONYL-OXYPHENYL} ETHOXY) PHENYL] PROPANOIC CRYSTALLINE FORM
AU2003238883A1 (en) A novel amorphous form of (2-(4-((4-chlorophenyl)-phenyl methyl)-1- piperazinyl) ethoxy) acetic acid dihydrochloride (cetirizine dihydrochloride)
IL164413A0 (en) (2-((-Alkoxy)-phenyl)-cyclopent-1-enyl)aromatic carbo and heterocyclic acid and derivatives
UA92770C2 (en) PROCESS FOR THE PREPARATION OF {2-[4-(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-PHENYL-P-CHLOROBENZYL)-PIPERAZIN-1-YL]-ETHOXY}-ACETIC ACID-N,N-DIMETHYLAMIDE AND ENANTIOMERS THEREOF
AU2002311328A1 (en) Terminal for controlling use of a computer
AU2002352962A1 (en) Novel-n-(4-(1h-imidazol-1-yl)-2-fluorophenyl)-3-(trifluoromethyl)-1-h-pyrazole-5-carboxamides as factor xa
PL367632A1 (en) Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperindinyl]-1-hydroxybutyl]-$g(a), $g(a)-dimethylbenzene acetic acid and its hydrochloride
AU2034601A (en) Crystalline form of 3-(4-(2-(4-tert-butoxycarbonylaminophenyl)ethoxy)phenyl)-(s) 2-ethoxy propanoic acid
HU0003005D0 (en) A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl) benzo (b)thiophene hydrochloride
AU2003277855A8 (en) Amorphous form of(-)-}2-}4-}(4-chlorophenyl)-phenyl methyl}-1-piperazinyl) ethoxy) acetic acid dihydrochloride (levocetririzine dihydrochloride)
WO2006056772A3 (en) Salts of quetiapine
ATE203237T1 (en) PSEUDOPOLYMORPHIC FORMS OF 2-(2-(4-(BIS(4- FLUOROPHENYL)METHYL)-1-PIPERAZINYL)ETHOXY)ACETIC ACID DIHYDROCHLORIDE
AU2003228011A1 (en) 2-(2-(4-((4-chlorophenyl) phenylmethyl)-1-piperazinyl)ethoxy)acetic acid monohydrochloride as anti-allergenic compound and process for its production
AU2003235814A1 (en) Novel process for the preparation of trans-3- ethyl-2,5- dihydro-4- methyl-n-(2-( 4-(((((4-methyl cyclohexyl) amino)carbonyl) amino)sulfonyl) phenyl)ethyl) -2-oxo-1h-pyrrole -1-carboxamide
AU2003244922A1 (en) 4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-benzamide for treating pulmonary fibrosis
AU2003297640A1 (en) Polymorphic forms of dihydrochloride salts of cetirizine and processes for preparation thereof
CA2269394A1 (en) A process for the preparation of esters of [2-[4-[(4-clorophenyl)phenylmethyl]-1-piperazinyl]-ethoxy]acetic acid
IS7056A (en) A pharmaceutical composition which either comprises (S) -2-ethoxy-3 [4- (2- {4-methanesulfonylloxyphenyl} ethoxy) phenyl] propanoic acid or 3- {4- [2- (4-tert-butoxycarbonylaminophenyl) ethoxy] phenyl } - (S) -2-ethoxy propanoic acid and insulin
MXPA03003432A (en) A novel crystalline form of 6 -hydroxy -3-(4 -[2-(piperidin -1-yl)ethoxy] phenoxy) -2-(4 -methoxyphenyl) benzo[b] thiophene hydrochloride.
AU2003247462A1 (en) Identification of a novel bhd gene
HUP0401039A3 (en) Process for the preparation of (3-cyano-1h-indol-7-yl)(4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof
WO2009057133A3 (en) A process for the synthesis of 2-[2-[4-[(4-chlorophenyl)phenyl methyl]-1-piperazinyl] ethoxy acetic acid

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 18, NO 7, PAGE(S) 1737 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME DR.REDDY S LABORATORIES LTD., APPLICATION NO. 2003238883, UNDER INID (71) CORRECT THE NAME TO READ DR.REDDY S LABORATORIES, INC.; DR.REDDY S LABORATORIES LTD.